Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Now It Really Is Personal: US FDA 'Rushing' To Develop Policy For 'Bespoke Therapies'
Jun 12 2019
•
By
Laura Helbling
It's a perfect fit, but the US FDA needs a way to see if it measures up.
More from Approval Standards
More from Pathways & Standards